SAN DIEGO, Oct. 20, 2022 (GLOBE NEWSWIRE) —

Uber Technologies, Inc. (NYSE: UBER)
Johnson Fistel, LLP, on behalf of Uber Technologies, Inc. (NYSE: UBER), is investigating potential claims against certain officers and directors.

If you are a current, long-term shareholder of Uber with shares prior to May 31, 2019, you may click or copy and paste the following link into a browser to participate in this promotion:

https://www.johnsonfistel.com/investigations/uber-technologies-derivative

A class action lawsuit was recently filed against Uber. The Complaint alleges that the Defendants made materially false and misleading statements regarding Uber’s business, operational and compliance policies throughout the Class Period. Specifically, Defendants have made false and/or misleading statements and/or failed to disclose that: (i) Uber had flawed disclosure controls and procedures; (ii) Uber has concealed and/or downplayed the full extent and seriousness of its past misconduct, including, without limitation, the extent to which it has covertly incited government officials and politicians to circumvent legal and regulatory requirements, and knowingly the security of Uber has risked Uber drivers to fuel the company’s global growth; (iii) as a result, Uber’s current global footprint and market share is, to a significant extent, the by-product of previously undisclosed, unsustainable and illegal business practices; (iv) all of this, once known, was likely to have a negative impact on Uber’s reputation and exposed the company to increased risk of regulatory and regulatory scrutiny and enforcement action; and (v) as a result, the Company’s public statements were, at all relevant times, materially false and misleading.

Co-Diagnostics, Inc. (NASDAQ:CODX)
Johnson Fistel, LLP is investigating potential claims against certain officers and directors on behalf of Co-Diagnostics, Inc. (“Co-Dx” or the “Company”) (NASDAQ: CODX).

If you’ve owned Co-Dx stock uninterrupted since May…